PRISM’s Biotech Breakfast

Healthcare Equities Reverse Declines, New Regulatory Wins for GLP-1 Drugs, AstraZeneca Joins Weight-Loss Drug Race Healthcare equities reversed earlier declines to close around their best… [Read More]